NEUROPHET, Inc. (KOSDAQ: A380550)
Health Care · Health Care Technology · KR
₩4,960.00
-7.12% today · -76.5% 1Y
Public summary
A free snapshot of NEUROPHET, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app NEUROPHET, Inc. (KOSDAQ: A380550) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $45.26M.
Over the last twelve months the share price has lost 76.5%, trading between 4.96K and 36.70K.
Tweenvest scores NEUROPHET, Inc. across four factors: quality 46/100, value 45/100. Its strongest factor is quality.
A380550 price history
Key figures
- Market cap
- $45.26M
- Revenue (TTM)
- $1.67M
- P/E
- -4.09
- EPS
- -2,302.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩36,700.00
- 52-week low
- ₩4,960.00
- Avg volume (3M)
- —
- Shares outstanding
- 12.20M
- Employees
- —
- Next earnings
- —
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Agfa-Gevaert NVENXTBR: AGFB | $54.66M | €0.32 | -3.88% |
| MedSci Healthcare Holdings LimitedSEHK: 2415 | $54.43M | HK$0.78 | 0.00% |
| Sancy BerhadKLSE: SANCY | $52.78M | RM0.32 | -11.11% |
| Mental Health Technologies Co.,Ltd.TSE: 9218 | $50.34M | ¥766.00 | +4.08% |
| Mentice AB (publ)OM: MNTC | $44.92M | Skr16.00 | +4.92% |
| Redwood AI Corp.CNSX: AIRX | $43.42M | CA$1.20 | 0.00% |
| Mach7 Technologies LimitedASX: M7T | $43.21M | AU$0.27 | +5.88% |
| Renalytix PlcAIM: RENX | $43.12M | £0.05 | 0.00% |